Children's Oncology Group's 2023 blueprint for research: Epidemiology.
cancer genetics
epidemiology
pediatric oncology
Journal
Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
30
06
2023
accepted:
03
07
2023
pmc-release:
01
09
2024
medline:
18
8
2023
pubmed:
14
7
2023
entrez:
14
7
2023
Statut:
ppublish
Résumé
The Children's Oncology Group (COG) Epidemiology Committee has a primary focus on better understanding the etiologies of childhood cancers. Over the past 10 years, the committee has leveraged the Childhood Cancer Research Network, and now more recently Project:EveryChild (PEC), to conduct epidemiologic assessments of various childhood cancers, including osteosarcoma, neuroblastoma, germ cell tumors, Ewing sarcoma, rhabdomyosarcoma, and Langerhans cell histiocytosis. More recent studies have utilized questionnaire data collected as part of PEC to focus on specific characteristics and/or features, including the presence of congenital disorders and the availability of stored cord blood. Members of the COG Epidemiology Committee have also been involved in other large-scale National Institutes of Health efforts, including the Childhood Cancer Data Initiative and the Gabriella Miller Kids First Pediatric Research Program, which are improving our understanding of the factors associated with childhood cancer risk. Future plans will focus on addressing questions surrounding health disparities, utilizing novel biospecimens in COG epidemiology studies, exploring the role of environmental factors on the etiologies and outcomes of childhood cancer, collaborating with other COG committees to expand the role of epidemiology in childhood cancer research, and building new epidemiologic studies from the Molecular Characterization Initiative-all with the ultimate goal of developing novel prevention and intervention strategies for childhood cancer.
Identifiants
pubmed: 37449937
doi: 10.1002/pbc.30566
pmc: PMC10519152
mid: NIHMS1930145
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e30566Subventions
Organisme : NIH HHS
ID : R01CA132887
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA249867
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA124709
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA233719
Pays : United States
Organisme : NIH HHS
ID : U10CA098413
Pays : United States
Organisme : NIH HHS
ID : R03CA272955
Pays : United States
Organisme : NCI NIH HHS
ID : U10 CA098543
Pays : United States
Organisme : NIH HHS
ID : U01CA122371
Pays : United States
Organisme : NIH HHS
ID : R01CA233719
Pays : United States
Organisme : NCI NIH HHS
ID : U10 CA180886
Pays : United States
Organisme : NIH HHS
ID : R01CA161780
Pays : United States
Organisme : NIH HHS
ID : U10CA098543
Pays : United States
Organisme : NIH HHS
ID : R01CA124709
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA122371
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA151284
Pays : United States
Organisme : NIH HHS
ID : R01CA262012
Pays : United States
Organisme : NCI NIH HHS
ID : R03 CA272955
Pays : United States
Organisme : NCI NIH HHS
ID : U10 CA098413
Pays : United States
Organisme : NIH HHS
ID : U10CA180899
Pays : United States
Organisme : NIH HHS
ID : U10CA180886
Pays : United States
Organisme : NCI NIH HHS
ID : U10 CA180899
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA132887
Pays : United States
Organisme : NIH HHS
ID : R01CA151284
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA262012
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA161780
Pays : United States
Informations de copyright
© 2023 Wiley Periodicals LLC.
Références
J Neurosurg Pediatr. 2016 Nov;18(5):585-593
pubmed: 27540957
Br J Cancer. 2018 Jan;118(1):121-126
pubmed: 29065103
Cancer. 2018 Oct 1;124(19):3900-3908
pubmed: 30291793
Cancer Discov. 2015 Sep;5(9):920-31
pubmed: 26084801
JAMA Oncol. 2020 May 1;6(5):724-734
pubmed: 32191290
J Clin Oncol. 2012 Jun 1;30(16):2005-12
pubmed: 22547602
Nat Commun. 2023 May 6;14(1):2636
pubmed: 37149691
Int J Cancer. 2018 Apr 15;142(8):1594-1601
pubmed: 29210060
J Clin Oncol. 2011 Jan 1;29(1):76-82
pubmed: 21098321
Am J Hum Genet. 2019 Sep 5;105(3):658-668
pubmed: 31474320
Cancer Epidemiol. 2019 Aug;61:165-171
pubmed: 31279991
J Natl Cancer Inst. 2023 Jun 8;115(6):733-741
pubmed: 36951526
J Natl Cancer Inst. 2021 Jul 1;113(7):875-883
pubmed: 33372952
Am J Hum Genet. 1998 Apr;62(4):969-78
pubmed: 9529360
Front Pediatr. 2021 Apr 23;9:639479
pubmed: 33968846
Genes Chromosomes Cancer. 2017 Jul;56(7):548-558
pubmed: 28295819
Bioessays. 2021 Sep;43(9):e2100030
pubmed: 34106479
Cancer Epidemiol Biomarkers Prev. 2020 Jun;29(6):1081-1094
pubmed: 32482635
Cancer Epidemiol. 2015 Oct;39(5):720-6
pubmed: 26159683
Am J Hum Genet. 2022 Jun 2;109(6):1026-1037
pubmed: 35512711
Cancer. 2022 Sep 1;128(17):3196-3203
pubmed: 35788992
Cancer Causes Control. 2016 Oct;27(10):1209-18
pubmed: 27541142
Blood. 2017 Nov 16;130(20):2229-2232
pubmed: 28935696
Pediatr Blood Cancer. 2022 Nov;69(11):e29933
pubmed: 36069432
J Endocrinol Metab. 2022 Jun;12(3):79-88
pubmed: 36249955
Paediatr Perinat Epidemiol. 2011 Nov;25(6):549-58
pubmed: 21980944
Pediatr Blood Cancer. 2016 Mar;63(3):428-35
pubmed: 26524117
Cancer. 2021 Oct 1;127(19):3651-3663
pubmed: 34151418
Pediatr Blood Cancer. 2023 May 17;:e30413
pubmed: 37194615
Br J Cancer. 2022 Jul;127(2):301-312
pubmed: 35368045
Int J Mol Epidemiol Genet. 2012;3(4):286-93
pubmed: 23205180
Br J Cancer. 2018 Oct;119(7):864-872
pubmed: 30287918
JCO Precis Oncol. 2020 Oct 2;4:
pubmed: 33163847